David Happel - Net Worth and Insider Trading
David Happel Net Worth
The estimated net worth of David Happel is at least $3 Million dollars as of 2024-05-10. David Happel is the President & CEO of Sagimet Biosciences Inc and owns about 639,200 shares of Sagimet Biosciences Inc (SGMT) stock worth over $3 Million. Details can be seen in David Happel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David Happel has not made any transactions after 2024-03-26 and currently still holds the listed stock(s).
Transaction Summary of David Happel
David Happel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Happel owns 3 companies in total, including Horizon Therapeutics PLC (HZNP) , Raptor Pharmaceutical Corp (RPTP) , and Sagimet Biosciences Inc (SGMT) .
Click here to see the complete history of David Happel’s form 4 insider trades.
Insider Ownership Summary of David Happel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2016-11-04 | EVP Global Orphan Bus. Unit |
| RPTP | Raptor Pharmaceutical Corp | 2016-10-24 | Chief Commercial Officer |
| SGMT | Sagimet Biosciences Inc | 2024-03-26 | director & President & CEO |
David Happel Latest Holdings Summary
David Happel currently owns a total of 1 stock. David Happel owns 639,200 shares of Sagimet Biosciences Inc (SGMT) as of March 26, 2024, with a value of $3 Million.
Latest Holdings of David Happel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc | 2024-03-26 | 639,200 | 4.57 | 2,921,144 |
Holding Weightings of David Happel
David Happel Form 4 Trading Tracker
According to the SEC Form 4 filings, David Happel has made a total of 3 transactions in Sagimet Biosciences Inc (SGMT) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Sagimet Biosciences Inc is the acquisition of 12,100 shares on March 26, 2024, which cost David Happel around $63,767.
Insider Trading History of David Happel
- 1
David Happel Trading Performance
GuruFocus tracks the stock performance after each of David Happel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Happel is 141.84%. GuruFocus also compares David Happel's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Happel within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Happel's insider trading performs compared to the benchmark.
Performance of David Happel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 54.09 |  | | | | |
| Relative Return to S&P 500(%) | 52.39 | | | | | |
David Happel Ownership Network
David Happel Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
David Happel is the EVP Global Orphan Bus. Unit of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
Over the past 18 months, David Happel made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 40,275 shares made by Jeffrey W Sherman , a net sale of 57,298 shares made by Andy Pasternak , and a net sale of 36,148 shares made by Aaron Cox .
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
David Happel Mailing Address
Above is the net worth, insider trading, and ownership report for David Happel. You might contact David Happel via mailing address: 7 Hamilton Landing, Suite 100, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
